technologynetworks

Decision Biomarkers Awarded U.S. Patent for Protein Array Surface Chemistry

Decision Biomarkers Inc (DBI) has announced the company's PATH® technology has been awarded United States Patent 7,297,497 by the U.S. Patent and Trademark Office. The patent applies to a novel, ultra ...
technologynetworks

Arrayjet Secures Protein Microarray Bioprinter Contract with CDI Laboratories

Arrayjet, a Scottish-based microarray instrumentation company, has secured a further contract with US-based Proteomics company, CDI Laboratories, which will further enhance CDI’s work in advancing ...
EurekAlert!

Emory University and Micron Biomedical launch first-in-human clinical trial of next-generation rotavirus vaccine delivered via dissolvable microarray technology

Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...
manilatimes

Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch” technology and utilizes Micron's first-in-class dissolvable microarray technology Research builds on Emory's ...
MarketWatch

Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology

The MarketWatch News Department was not involved in the creation of this content. -- Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch" technology and utilizes ...